Loading stock data…
Loading stock data…
US$123.61
Get one email when MRK crosses your level. Checked every 15 minutes during market hours.
▲ +2.83 (2.34%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
51.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
1.48
Bearish momentumMACD below its signal line (2.12).
50-day average
118.95
Price aboveShort-term trend reference.
200-day average
109.01
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Drug Manufacturers - General
Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio features prominent human health pharmaceuticals such as Keytruda for oncology treatments, Welireg for specific cancer therapies, and Gardasil for HPV prevention. The company also provides a robust lineup of vaccines including ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, and Pneumova…
www.merck.com9 strong buy · 16 buy · 11 hold · 0 sell · 0 strong sell (36 analysts, 2026-07-01)
9 strong buy · 16 buy · 11 hold · 0 sell · 0 strong sell (36 analysts, 2026-06-01)
8 strong buy · 17 buy · 10 hold · 0 sell · 0 strong sell (35 analysts, 2026-05-01)
8 strong buy · 16 buy · 11 hold · 0 sell · 0 strong sell (35 analysts, 2026-04-01)
Companies in the same industry, via Finnhub